Product Details

Clavulin

Amoxicillin + Clavulanic Acid
25 mg + 6.25 mg/mL
Powder for Oral Suspension


DIN/PIN/NPN

01916882

Manufacturer

GlaxoSmithKline Inc., GlaxoSmithKline Consumer Health Care

Formulary Listing Date

1996-10-01  

Unit Price

0.1173

Amount MOH Pays

0.1173

Coverage Status

General Benefit

ODB Formulary Therapeutic Classification

Therapeutic Note

Amoxicillin + Clavulanic Acid: Amoxicillin/clavulanic acid is not recommended as first line treatment for acute otitis media and sinusitis. Antibiotic resistance (H. influenzae, M. catarrhalis) due to B-lactamase production has caused only a minority of treatment failures with amoxicillin. Amoxicillin/clavulanic acid is first line treatment for infected bites of cat, dog or human.

ATC Code

J01CR02

Interchangeable Products

NO  

LU Clinical Criteria

NO  

EAP Criteria

NO

Product Monograph

View Monograph